Document is current
Any future updates will be listed below
-
Authors
Cwiek, Aleksandra
Dailey, Rachel K.
Kameshwar, Ayyappa Kumar Sista
Suzuki, Masako
Isaac, Jaya
deRonde, Kimberly
Conaway, Mark
Bennett, Kevin M.
Baldelomar, Edwin J.
Li, Teng
Wu, Teresa
Hoch, Matthew R.
Chavkin, Nicholas W.
Walker, Patrick D.
Hirschi, Karen K.
Reidy, Kimberly J.
Charlton, Jennifer R.
-
Funding
Funding for this research was provided by:
American Heart Association (23PRE1026720)
National Institute of Diabetes and Digestive and Kidney Diseases (R01HD111052, R01HD111052, R01HD111052, R01HD111052, R01HD111052, R21DK134104-01, R01HD111052, R01HD111052)
National Institutes of Health (U24DK115255-04)
- License Information
-
More Information
Article History
Received: 16 October 2024
Accepted: 24 April 2025
First Online: 29 May 2025
Declarations
:
: The authors declare no competing interests.
: JRC: VP of NKC; owner of Sindri Technologies LLC, investor in ZorroFlow and consultant for Mozarc Medical; KMB: Co-owner of Sindri Technologies LLC, Co-owner of XN Biotechnologies LLC; EJB: Co-owner of XN Biotechnologies LLC.
